Clinical Research
Patients Characteristics and Outcome of 518 Arteriovenous Fistulas for Hemodialysis in a Sub-Saharan African Setting

Presented at the 7th Congress of the Cameroon Cardiac Society, Yaounde, Cameroon, March 18, 2010. Abstract in Cardiovasc J Afr 2010;21.
https://doi.org/10.1016/j.avsg.2011.07.019Get rights and content

Background

To present the particular aspects of arteriovenous fistula (AVF) for hemodialysis in sub-Saharan Africa in terms of patients’ characteristics, patency and complication rates, as well as factors influencing them.

Methods

From November 2002 to November 2009, 518 fistulas were constructed on adults. Demographic data, patency, and complications were analyzed. The association between age, sex, and comorbidities (HIV, hypertension, diabetes) on one hand and complications as well as AVF patency on the other was sought.

Results

Males represented 73.7% of the patient population, and the mean age of the population was 45.3 years. As far as etiologies of end-stage renal disease (ESRD) and comorbidities are concerned, chronic glomerulonephritis was the leading cause of ESRD (134; 25.9%), followed by hypertension (22.3%), although prevalent in 83.2% of patients, and diabetes (20.1%), although prevalent in 22.2%. No cause for the ESRD could be identified in 89 patients (17.2%). Only 20.64% had AVF as the initial vascular access. The main types of AVF constructed were radiocephalic (68%) and brachiocephalic (24.9%). The median follow-up period was 275 days. The cumulative patency rate at 1 year and 2 years was 76% and 51%, respectively. Altogether, 188 complications occurred in 16% of the AVFs. Aneurysms, failure to mature, and thrombosis were the most frequent complications occurring in 27.65%, 14.89%, and 10.63% of cases, respectively. The management options for the complications included the creation of a new access for 63 complications (33.51%) and nonoperative management in 44.14% of the cases. We found no adverse effect of comorbid factors like diabetes mellitus (χ2 = 3.58, P > 0.05) and HIV-positive status (χ2 = 0.64, P > 0.05) on the complications rate.

Conclusion

According to our patients’ characteristics, there is a possibility of constructing AVF on nearly every hemodialysis patient with a good outcome.

Introduction

Since the advent of hemodialysis in 1944, and the subsequent use of arteriovenous fistulae (AVFs) as a long-term vascular access,1 there has been a drastic increase in both the availability of hemodialysis and long-term survival of patients with chronic renal failure. This has resulted in permanent vascular access procedures in dialysis (AVFs, prosthetic arteriovenous grafts, and autologous vein grafts) becoming the most common operations performed by vascular surgeons. Because of data illustrating superiority of AVF in terms of patency rates, lower complication rate, and lower costs, it has been recommended in countries such as United States that AVF should be constructed in at least 50% of patients on chronic hemodialysis.2 This goal has even been raised to 65% in recent guidelines.3

In developing countries and particularly in sub-Saharan Africa, there are very few reports concerning vascular access surgery4, 5 compared with North Africa6, 7, as hemodialysis is not yet widespread in these areas. In Cameroon, since the year 2000, hemodialysis is accessible to many. Therefore, construction and maintenance of vascular accesses has become a challenge.

In this report, we present the particularities of AVF for hemodialysis in our setting. Specifically, we sought to audit the patients’ characteristics, the complications, patency rates, and to determine factors that affect these outcomes. To the best of our knowledge, this is the largest published report concerning vascular access surgery in sub-Saharan Africa.

Section snippets

Methods

We retrospectively evaluated upper-limb AVFs performed between November 2002 and 2009 at the Yaoundé General Hospital—a university teaching hospital with most modern facilities for vascular surgery and hemodialysis—in Cameroon. The cases included in the study were consecutive adult patients with end-stage renal disease (ESRD) referred for the creation of AVF (8 patients aged <16 years were not considered for this study). Primary (firstly created) and secondary (all subsequently constructed)

Sociodemographic Data

During the 7-year study period, 518 upper-arm vascular accesses were created on 492 limbs on 478 patients. Of these, 382 were males, representing 73.7% of the population. Two patients who relocated overseas for kidney grafting were not included in this analysis. The mean age of the patients at time of surgery was 45.33 (range: 17–74) years.

As far as etiologies of ESRD and comorbidities are concerned, chronic glomerulonephritis was the leading cause of ESRD (134; 25.9%), followed by hypertension

Discussion

The proportion of patients commencing dialysis with an AVF was only 20.65%, whereas 79.35% initiated dialysis with temporary central venous catheter. The late presentation of patients with ESRD for specialized care (owing to late referral from nonspecialized centers, geographical distance, ignorance, and low income) has been described earlier in our setting.8 This late presentation at end stage with uremic complications requires emergency renal replacement therapy.8, 9 Therefore, central venous

Conclusion

In this study, we reported our 7-year experience in vascular access surgery in a setting where access to prosthetic graft is seldom, and showed that in nearly every patient with the same characteristics, it is possible to construct an AVF in the course of dialysis with a good outcome. There were no effects of HIV status on the outcome of the fistula. Although not specifically analyzed, we think there is a positive effect of low income and insurance status in the effort to always try to

References (27)

  • Clinical practice guidelines for vascular access 2000

    Am J Kidney Dis

    (2001)
  • Clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy, vascular access

    Am J Kidney Dis

    (2006)
  • E.A. Nwankwo et al.

    Practice pattern of hemodialysis vascular access in Maiduguri, Nigeria

    Int J Artif Organs

    (2006)
  • Cited by (11)

    • Interest of surgical vascular reconstructions aiming at preserving hemodialysis access

      2022, JMV-Journal de Medecine Vasculaire
      Citation Excerpt :

      The morbidity rate in our reconstruction series was 41.8%, comparable to the few studies that have reported this outcome. It varies from 11.4% to 64% in the literature [6–8]. This rate is essentially related to the high number of comorbidities and the use of prosthetic material for the creation or reconstruction of the AVF [4].

    • End Stage Renal Disease in Sub-Saharan Africa

      2017, Chronic Kidney Disease in Disadvantaged Populations
    • Access for renal replacement therapy

      2013, Kidney Transplantation-Principles and Practice, Seventh Edition
    View all citing articles on Scopus

    Presented at the Joint Congress of German, Austrian, and Switzerland Societies of Vascular Surgery, Berlin, Germany, September 10, 2010. Abstract in Ao3.3.1.4 Gefäßchirurgie 2010;15:379.

    View full text